Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock to $17.63
Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share
Categories
LATEST
Initial response to single-serve pour-over product is the driver behind NuZee’s business: CEO
NuZee, Inc. (NASDAQ: NUZE) is a leading coffee technology and co-packing company that provides end-to-end sustainable solutions for clients ranging from small
Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific
Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a share price
Ocean Biomedical (OCEA) set to join the Russell 2000 Index
Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index, effective after
Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment
Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad patent for
Ocean Biomedical announces private placement of $25 mln convertible notes
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a securities purchase
MCHP Earnings: Microchip Technology Q4 2023 sales and profit increase
Microchip Technology Inc. (NASDAQ: MCHP) has announced financial results for the fourth quarter of 2023, reporting a 21% growth in net sales.
H&R Block, Inc. (HRB) Q3 2023 Earnings Call Transcript
H&R Block, Inc. (NYSE: HRB) Q3 2023 Earnings Call dated May. 09, 2023 Corporate Participants: Michaella Gallina -- Vice President of Investor
Apple (AAPL) Q2 2023 sales down 3%; results beat estimates
Gadget giant Apple Inc. (NASDAQ: AAPL) on Thursday said its second-quarter 2023 sales declined from last year, reflecting lower Mac and iPad
Advanced Micro Devices sees recovery in second half. Is the stock a buy?
Semiconductor company Advanced Micro Devices, Inc. (NASDAQ: AMD) had an unimpressive start to the new fiscal year, reporting weak numbers for the
Shake Shack Inc Class A (SHAK) Q1 2023 Earnings Call Transcript
Shake Shack Inc Class A (NYSE: SHAK) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Annalee Leggett -- Director of Investor Relations
Blue Apron Holdings Inc (APRN) Q1 2023 Earnings Call Transcript
Blue Apron Holdings Inc (NYSE: APRN) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Linda Findley Kozlowski -- President and
Papa Johns International Inc (PZZA) Q1 2023 Earnings Call Transcript
Papa Johns International Inc (NASDAQ:PZZA) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Stacy Frole -- Vice President of Investor Relations Robert
Trxade Health Inc. (NASDAQ: MEDS) Q1 2023 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform. It is
Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17
Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said its scientific co-founder Jack Elias published new findings in Cancer Research, a peer-reviewed
Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and commercializing their
Ocean Biomedical co-founder Jack Elias to receive US patent for pulmonary fibrosis treatments
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and commercializing their
JB Hunt Transport Services Inc. (JBHT) Q1 2023 Earnings Call Transcript
JB Hunt Transport Services Inc. (NASDAQ: JBHT) Q1 2023 earnings call dated Apr. 17, 2023 Corporate Participants: Brad Delco -- Senior Vice President, Finance
Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing their discoveries,
Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a platform to